QLGN Stock Earnings: Qualigen Therapeutics Reported Results for Q2 2024

    Date:

    Qualigen Therapeutics (NASDAQ:QLGN) just reported results for the second quarter of 2024.

    • Qualigen Therapeutics reported earnings per share of -20 cents.
    • The company did not report any revenue for the quarter.

    InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

    Chart

    SignUp For Breaking Alerts

    New Graphic

    We respect your email privacy

    Share post:

    Popular

    More like this
    Related

    Here’s How Much You Would Have Made Owning Apple Stock In The Last 15 Years

    Apple AAPL has outperformed the market over the past...

    Marijuana Stock Movers For December 25, 2024

    GAINERS: LOSERS: This article was generated by Benzinga's automated content engine...

    P/E Ratio Insights for Portland Gen Electric

    In the current market session, Portland Gen Electric Inc....

    Peering Into Intuitive Machines’s Recent Short Interest

    Intuitive Machines's LUNR short percent of float has fallen...